| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 500 | $41.67 | $20,836.95 | -0.6% | +3.4% | -43.3% | |
| Apr 30, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $237.00 | $1,706,365.61 | -32.7% | +43.1% | +29.3% | |
| Apr 29, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 478,331 | $0.09 | $41,128.94 | - | - | - | |
| Apr 29, 2024 | HIMS Hims & Hers Health, Inc. | Boughton Soleil | Chief Legal Officer | Sell | 2,503 | $12.56 | $31,437.68 | -1.5% | +73.0% | +179.2% | |
| Apr 29, 2024 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 7,470 | $0.08 | $590.13 | +1.0% | - | - | |
| Apr 29, 2024 | MRMD Marimed Inc. | Levine Jon R | President And CEO | Sell | 50,031 | $0.26 | $12,772.91 | -0.2% | - | - | |
| Apr 29, 2024 | MRMD Marimed Inc. | Shaw Timothy | Chief Operating Officer | Sell | 40,205 | $0.26 | $10,264.34 | -0.5% | - | - | |
| Apr 26, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 20,000 | $0.07 | $1,380.00 | - | - | - | |
| Apr 26, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $235.36 | $1,694,624.89 | -54.0% | +43.8% | +24.6% | |
| Apr 25, 2024 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 20,000 | $9.97 | $199,400.00 | +0.5% | +138.7% | +155.5% | |
| Apr 25, 2024 | ETST Earth Science Tech, Inc. | Sanchez Yovan Arturo | Director | Buy | 92,530 | $0.06 | $5,459.27 | +6.7% | - | - | |
| Apr 24, 2024 | BSPK Bespoke Extracts, Inc. | Feinsod Michael | CEO | Buy | 5,000 | $0.11 | $550.00 | +0.2% | - | - | |
| Apr 24, 2024 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 20,000 | $10.23 | $204,640.10 | +0.3% | +138.4% | +144.1% | |
| Apr 24, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $237.60 | $1,710,712.86 | -27.7% | +42.1% | +25.1% | |
| Apr 22, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 79,000 | $0.07 | $5,165.00 | - | - | - | |
| Apr 22, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $236.69 | $1,704,173.99 | -40.2% | +42.1% | +25.1% | |
| Apr 20, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 40,000 | $0.07 | $2,797.97 | - | - | - | |
| Apr 19, 2024 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 29,400 | $10.56 | $310,390.50 | +0.8% | +135.3% | +122.4% | |
| Apr 19, 2024 | LQDA Liquidia Corp | Saggar Rajeev | Chief Medical Officer | Sell | 1,649 | $13.68 | $22,558.32 | -0.8% | -17.4% | -0.2% | |
| Apr 19, 2024 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 27,232 | $65.10 | $1,772,729.07 | -1.7% | -6.3% | +3.9% | |
| Apr 18, 2024 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 923 | $151.17 | $139,529.91 | -5.9% | +18.9% | -2.9% | |
| Apr 18, 2024 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | CEO | Buy | 89,000 | $0.07 | $5,958.93 | - | - | - | |
| Apr 18, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $236.80 | $1,704,990.23 | -29.0% | +39.9% | +20.2% | |
| Apr 17, 2024 | ANIP Ani Pharmaceuticals Inc | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 22,768 | $65.91 | $1,500,589.42 | -0.9% | -1.9% | +5.7% | |
| Apr 16, 2024 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 7,200 | $233.72 | $1,682,818.90 | -37.3% | +41.2% | +23.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.